Physician profile
Annette Kyzer
NPI 1669448593
$1,119.65
in general payments reported to CMS, 2019-2025
15 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $65.36 · 2021: $68.80 · 2022: $35.56 · 2024: $220 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560 · Travel and Lodging: $7.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.00 |
| Travel and Lodging | $7.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $377.40 | 2019-2025 | Unifi Workspace, Thinprep 2000 Processor, 3dimensions |
| Smith+Nephew, INC. | $153.56 | 2025 | Pico |
| Bayer Healthcare Pharmaceuticals INC. | $111.06 | 2019-2020 | |
| Abbvie INC. | $106.08 | 2019-2022 | |
| Coopersurgical, INC. | $68.00 | 2019-2021 | |
| Allergan, INC. | $59.70 | 2019-2020 | |
| Duchesnay USA Incorporated | $57.28 | 2019 | |
| Hologic INC | $50.95 | 2025 | 3dimensions |
| Lupin INC. | $29.88 | 2019 | |
| Avion Pharmaceuticals | $29.75 | 2021 | |
| Mylan Pharmaceuticals INC. | $23.23 | 2019-2020 | |
| Emd Serono, INC. | $15.34 | 2024 | |
| Daiichi Sankyo INC. | $14.82 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.73 | 2019 | |
| Merck Sharp & Dohme LLC | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette Kyzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.